NHI stock hits 52-week low at 64.51 USD
National Health Investors Inc. (NHI) stock plummeted to its 52-week low of 64.51 USD, marking a substantial 13.94% decline over the past year. InvestingPro analysis suggests the stock is in oversold territory, while its Fair Value calculation indicates potential undervaluation. The REIT maintains an appealing 5.74% dividend yield, backed by 36 years of consecutive payments.
The stock's drop highlights the challenges faced by NHI, a real estate investment trust specializing in senior housing and medical properties. Analysts offer price targets ranging from $73 to $90, hinting at potential upside from current levels. Investors are closely watching NHI's performance as it navigates the changing healthcare landscape and economic conditions affecting its sector.
The company reported strong earnings for Q2 2026, surpassing Wall Street's profit expectations with an adjusted earnings per share of $1.15, compared to the forecasted $0.87. However, revenue fell short at $68.9 million, below the estimated $71.52 million. NHI also increased its quarterly dividend by $0.02, raising it to $0.94 per share.
The company sold its NHC portfolio for $560 million, expected to generate a substantial gain in Q3. NHI is shifting its focus towards senior housing operating properties, now comprising 24% of its assets. Truist Securities updated its price target to $80 from $81, maintaining a Buy rating due to revised funds from operations estimates for 2026 and 2027, despite a $0.07 per share shortfall in Q2.
BMO Capital reiterated an Outperform rating on NHI, maintaining its price target at $80. These developments reveal ongoing adjustments and strategic moves by National Health Investors as it adapts to the evolving market environment.
Rewritten by urgent.news; may contain errors — check the original.